Junichi Terashima: Department of Pharmacy, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489- 8642, Japan.
Takahiro Kambara: Department of Cardiovascular Medicine, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
Eisei Hori: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan. ehori@phar.nagoya-cu.ac.jp.
Masahiro Fukatsu: Department of Pharmacy, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489- 8642, Japan.
Yukina Ichiki: Department of Pharmacy, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489- 8642, Japan.
Eri Oki: Department of Pharmacy, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489- 8642, Japan.
Risako Koketsu: Department of Pharmacy, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489- 8642, Japan.
Rika Taguchi: Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
Suzuka Mii: Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
Ryoka Hiro: Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
Teruhiro Sakaguchi: Department of Cardiovascular Medicine, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
Hiroyuki Osanai: Department of Cardiovascular Medicine, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
Tomoya Tachi: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
Tadashi Suzuki: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
BACKGROUND: Heart failure has a high readmission rate, but interventions by multiple professionals are effective. Although there is growing interest in the management of Heart failure by community pharmacists in Japan, no effective method has been developed. We created and verified the effectiveness of a novel Heart failure management protocol that community pharmacists could utilize. METHODS: This study included 68 patients (80.8��������11.8 years; male, 60.3%) diagnosed with Heart failure who was admitted to our hospital between March 2022 and September 2023. A protocol was developed for the regular follow-up of patients and responses to exacerbations, in collaboration with pharmacists. patients who were able to receive follow-up from community pharmacists were included in the intervention group, otherwise they were included in the control group. The primary endpoint was readmission, and the secondary endpoint was a composite of readmission, all-cause death, hospitalization, and dialysis due to dehydration or renal dysfunction. RESULTS: The Kaplan-Meier analysis (p���=���0.021) and Cox model (hazard ratio: 0.28, 95% confidence interval: 0.09-0.89, p���=���0.031) revealed a significantly lower incidence of Heart failure readmission within 360 days in the intervention group than in the control group. CONCLUSIONS: The implementation of a Heart failure management protocol that provides clear guidance on appropriate patient management enabled pharmacists to effectively reduce the likelihood of adverse events, such as Heart failure readmission. THE REGISTRATION NUMBER: UMIN000046750, registered on February 1, 2022.
Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190���5. https://doi.org/10.1136/annrheumdis-2012-201531 .
[DOI: 10.1136/annrheumdis-2012-201531]
Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. 1999;354:1077���83. https://doi.org/10.1016/s0140-6736(99)03428-5 .
[DOI: 10.1016/s0140-6736(99)03428-5]
Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83���9. https://doi.org/10.1016/s0735-1097(01)01699-0 .
[DOI: 10.1016/s0735-1097(01)01699-0]
Tsuchihashi-Makaya M, Mastuo H, Kakinoki S, Takeuchi S, Tsutsui H, Investigators J-HOMECARE. Rationale and design of the Japanese heart failure outpatients disease management and cardiac evaluation (J-HOMECARE). J Cardiol. 2011;58:165���72. https://doi.org/10.1016/j.jjcc.2011.04.004 .
[DOI: 10.1016/j.jjcc.2011.04.004]
Tsuchihashi-Makaya M, Mastuo H, Kakinoki S, Takeuchi S, Tsutsui H. J-HOMECARE investigators. Home-based disease management program to improve psychological status in patients with heart failure in Japan. Circ J. 2013;77:926���33. https://doi.org/10.1253/circj.cj-13-0115 .
[DOI: 10.1253/circj.cj-13-0115]
Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure - A study in Fukuoka, Japan -. Jpn Circ J. 2000;64:953���9. https://doi.org/10.1253/jcj.64.953 .
Weber ZA, Kaur P, Hundal A, Ibriga SH, Bhatwadekar AD. Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures. Pharm Pract. 2019;1:1319���24. https://doi.org/10.18549/PharmPract.2019.1.1319 .
[DOI: 10.18549/PharmPract.2019.1.1319]
Luder HR, Frede SM, Kirby JA, Epplen K, Cavanaugh T, Martin-Boone JE, et al. TransitionRx: impact of community pharmacy postdischarge medication therapy management on hospital readmission rate. J Am Pharm Assoc. 2015;55:246���54. https://doi.org/10.1331/JAPhA.2015.14060 .
[DOI: 10.1331/JAPhA.2015.14060]
Parajuli DR, Kourbelis C, Franzon, Newman P, Mckinnon RA, Shakib S, et al. Effectiveness of the Pharmacist-Involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: A systematic review and Meta-Analysis of randomized controlled trials. J Card Fail. 2019;25:744���56. https://doi.org/10.1016/j.cardfail.2019.07.455 .
[DOI: 10.1016/j.cardfail.2019.07.455]
Gattis WA, Hasselblad V, Whellan DJ, O���Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med. 1999;159:1939���45. https://doi.org/10.1001/archinte.159.16.1939 .
[DOI: 10.1001/archinte.159.16.1939]
Cheng-Lai A, Prlesi L, Murthy S, Bellin EY, Sinnett MJ, Goriacko P. Evaluating Pharmacist-Led heart failure transitions of care clinic: impact of analytic approach on readmission rate endpoints. Curr Probl Cardiol. 2023;48:101507. https://doi.org/10.1016/j.cpcardiol.2022.101507 .
[DOI: 10.1016/j.cpcardiol.2022.101507]
Jasi��ska-Stroschein M, Waszyk-Nowaczyk M. Multidimensional interventions on supporting disease management for hospitalized patients with heart failure: the role of clinical and community pharmacists. J Clin Med. 2023;12:3037. https://doi.org/10.3390/jcm12083037 .
[DOI: 10.3390/jcm12083037]
Chaudhry S, Wang Y, Gill TM. Krumholz. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007; 116 1549���54. https://doi.org/10.1161/CIRCULATIONAHA.107.690768
Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, K��ber L, Andersen J, et al. One-Year mortality after intensification of outpatient diuretic therapy. J Am Heart Assoc. 2020;9:e016010. https://doi.org/10.1161/JAHA.119.016010 .
[DOI: 10.1161/JAHA.119.016010]
Ahmed A, Husain A, Love TE, Gambassi G, Dell���Italia LJ, Francis GS, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27:1431���9. https://doi.org/10.1093/eurheartj/ehi890 .
[DOI: 10.1093/eurheartj/ehi890]
Jones CD, Holmes GM, Dewalt DA, Erman B, Broucksou K, Hawk V, et al. Is adherence to weight monitoring or weight-based diuretic self-adjustment associated with fewer heart failure-related emergency department visits or hospitalizations? J Card Fail. 2012;18:576���84. https://doi.org/10.1016/j.cardfail.2012.05.004 .
[DOI: 10.1016/j.cardfail.2012.05.004]
Takai Y, Kajima Y, Nishikawa H. Effects of continuous intervention by pharmacists on medication adherence���in patients with heart failure. Japanese J Pharm Health Care Sci. 2017;43:388���93. https://doi.org/10.5649/jjphcs.43.388 .
[DOI: 10.5649/jjphcs.43.388]
Takai Y, Kajima Y. Effects of Cooperation intervention by hospital pharmacists and community pharmacists. Japanese J Pharm Health Care Sci. 2020;46:279���84. https://doi.org/10.5649/jjphcs.46.279 .
[DOI: 10.5649/jjphcs.46.279]
Suzuki M, Matsue Y, Izumi S, Kimura A, Hashimoto T, Otomo K, Saito H, et al. Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication. Heart Vessels. 2018;33:615���22. https://doi.org/10.1007/s00380-017-1099-8 .
[DOI: 10.1007/s00380-017-1099-8]
Sato Y, Kuragaichi T, Nakayama H, Hotta K, Nishimoto Y, Kato T, et al. Developing multidisciplinary management of heart failure in the Super-Aging society of Japan. Circ J. 2023;88:2���9. https://doi.org/10.1253/circj.CJ-22-0675 .
[DOI: 10.1253/circj.CJ-22-0675]
Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D. Yoshiki h���et al: JCARECARD investigators. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese cardiac registry of heart failure in Cardiology(JCARE-CARD). Circ J. 2009;73:1893���900. https://doi.org/10.1253/circj.cj-09-0254 .
[DOI: 10.1253/circj.cj-09-0254]
